Nanomedicine: Nanotechnology, Biology and Medicine 2017-11-16

Silver-nanoparticles increase bactericidal activity and radical oxygen responses against bacterial pathogens in human osteoclasts

Valerie Aurore, Fabienne Caldana, Marianne Blanchard, Solange Kharoubi Hess, Nils Lannes, Pierre-Yves Mantel, Luis Filgueira, Michael Walch

Index: 10.1016/j.nano.2017.11.006

Full Text: HTML

Abstract

Bone infections are difficult to treat and can lead to severe tissue destruction. Acute bone infections are usually caused by Staphylococcus aureus. Osteoclasts, which belong to the monocyte/macrophage lineage, are the key cells in bone infections. They are not well equipped for killing bacteria and may serve as a reservoir for bacterial pathogens. Silver has been known for centuries for its bactericidal activity. Here, we investigated the bactericidal effects of nano-silver particles in bacteria infected human osteoclasts. We found that nano-silver in per se non-toxic concentration enhanced the bactericidal activity in osteoclasts against intracellular Methicillin-resistant, virulent Staphylococcus aureus. The reduced bacterial survival in nano-silver pretreated cells correlated with increased reactive oxygen responses towards the invading pathogens. Overall, these results indicate that nano-silver compounds should be considered as an effective treatment and prevention option for bacterial bone and orthopedic implant infections.

Latest Articles:

High sensitive and multiple detection of Acute Myocardial Infarction Biomarkers based on a dual-readout Immunochromatography Test Strip ☆ ☆☆

2018-03-28

[10.1016/j.nano.2018.02.013]

Screening for canine transitional cell carcinoma (TCC) by SERS-based quantitative urine cytology ☆ ☆☆ ☆☆☆

2018-03-27

[10.1016/j.nano.2018.03.001]

Nanomagnetic Modulation of Tumor Redox State ☆

2018-03-26

[10.1016/j.nano.2018.03.002]

Polymersome nanoparticles for delivery of Wnt-activating small molecules ☆ ☆☆

2018-03-17

[10.1016/j.nano.2018.02.014]

In Vitro Studies of Heparin-Coated Magnetic Nanoparticles for Use in the Treatment of Neointimal Hyperplasia ☆

2018-03-08

[10.1016/j.nano.2018.02.011]

More Articles...